Psoriasis drug ORKA-001 tested for Long-Term safety in extension trial
NCT ID NCT07449702
First seen Mar 05, 2026 · Last updated May 15, 2026 · Updated 11 times
Summary
This study looks at the long-term safety and how well ORKA-001 works for adults with moderate-to-severe plaque psoriasis. Participants must have completed a previous Oruka Therapeutics study. The main goal is to track side effects and see if skin clearing is maintained or improved over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Oruka Therapeutics Investigative Site
RECRUITINGLos Angeles, California, 90045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oruka Therapeutics Investigative Site
RECRUITINGSan Diego, California, 92123, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oruka Therapeutics Investigative Site
RECRUITINGSanta Ana, California, 92701, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oruka Therapeutics Investigative Site
RECRUITINGSanta Monica, California, 90404, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oruka Therapeutics Investigative Site
RECRUITINGCromwell, Connecticut, 06416, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oruka Therapeutics Investigative Site
RECRUITINGCoral Gables, Florida, 33134, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oruka Therapeutics Investigative Site
RECRUITINGBowling Green, Kentucky, 42104, United States
Contact Email: •••••@•••••
-
Oruka Therapeutics Investigative Site
RECRUITINGRockville, Maryland, 20850, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oruka Therapeutics Investigative Site
RECRUITINGDetroit, Michigan, 48202, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oruka Therapeutics Investigative Site
RECRUITINGNew York, New York, 10023, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oruka Therapeutics Investigative Site
RECRUITINGNew York, New York, 10029, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oruka Therapeutics Investigative Site
RECRUITINGPortland, Oregon, 97201, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oruka Therapeutics Investigative Site
RECRUITINGSurrey, British Columbia, V3R 6A7, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oruka Therapeutics Investigative Site
RECRUITINGLondon, Ontario, N6H 5L5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oruka Therapeutics Investigative Site
RECRUITINGMarkham, Ontario, L3P 1X3, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oruka Therapeutics Investigative Site
RECRUITINGPeterborough, Ontario, K9J 5K2, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oruka Therapeutics Investigative Site
RECRUITINGToronto, Ontario, M4W 2N4, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.